Elicio Therapeutics, Inc.

Q2 2023 13F Holders

Symbol
ELTX
CUSIP
28657F103
Type
Equity
Class
COM
Num filings
16
Total reported value, excl. options
$2.71 M
Manager Report Date Value ($000) Shares Option Type